Targeting angiogenesis for the treatment of prostate cancer

Author： Antonarakis Emmanuel S   Carducci Michael A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.4, 2012-04, pp. : 365-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis inhibitors in the treatment of prostate cancer

By Kluetz Paul G   Figg William D   Dahut William L  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 233-247

Informa Healthcare

Access to resources Recommend Favorite

Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 146-155

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-01 ,pp. : 566-581

Bentham Science Publishers

Access to resources Recommend Favorite

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 733-744

Bentham Science Publishers

Access to resources Recommend Favorite